| 000 | 00804 a2200229 4500 | ||
|---|---|---|---|
| 005 | 20250513155456.0 | ||
| 264 | 0 | _c19981124 | |
| 008 | 199811s 0 0 eng d | ||
| 022 | _a0952-7915 | ||
| 024 | 7 |
_a10.1016/s0952-7915(98)80213-6 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aGillis, S | |
| 245 | 0 | 0 |
_aCytokine therapy: lessons learned and future challenges. _h[electronic resource] |
| 260 |
_bCurrent opinion in immunology _cOct 1998 |
||
| 300 |
_a501-3 p. _bdigital |
||
| 500 | _aPublication Type: Editorial | ||
| 650 | 0 | 4 |
_aCytokines _xantagonists & inhibitors |
| 650 | 0 | 4 | _aHumans |
| 700 | 1 | _aWilliams, D E | |
| 773 | 0 |
_tCurrent opinion in immunology _gvol. 10 _gno. 5 _gp. 501-3 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0952-7915(98)80213-6 _zAvailable from publisher's website |
| 999 |
_c9804147 _d9804147 |
||